Dennis Langer - May 29, 2025 Form 4 Insider Report for Quoin Pharmaceuticals, Ltd. (QNRX)

Role
Director
Signature
/s/ Dennis Langer
Stock symbol
QNRX
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 08:38 PM
Previous filing
Dec 10, 2024
Next filing
Aug 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LANGER DENNIS Director C/O QUOIN PHARMACEUTICALS LTD.,, 42127 PLEASANT FOREST COURT, ASHBURN /s/ Dennis Langer 2025-06-02 0001274225

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNRX Share Option (Right to Buy) Award $0 +7.76K $0.00 7.76K May 29, 2025 ADS 7.76K $9.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer.
F2 The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.